Outlook Therapeutics (OTLK) Shares Issued: 2015-2020
Historic Shares Issued for Outlook Therapeutics (OTLK) over the last 2 years, with Sep 2020 value amounting to $691,456.
- Outlook Therapeutics' Shares Issued rose 69145500.00% to $691,456 in Q3 2020 from the same period last year, while for Sep 2020 it was $26.1 million, marking a year-over-year decrease of 43.11%. This contributed to the annual value of $60.3 million for FY2024, which is 100.95% up from last year.
- As of Q3 2020, Outlook Therapeutics' Shares Issued stood at $691,456, which was down 95.68% from $16.0 million recorded in Q2 2020.
- Outlook Therapeutics' 5-year Shares Issued high stood at $26.2 million for Q2 2019, and its period low was -$160,968 during Q3 2018.
- For the 3-year period, Outlook Therapeutics' Shares Issued averaged around $8.0 million, with its median value being $7.9 million (2019).
- In the last 5 years, Outlook Therapeutics' Shares Issued slumped by 99.97% in 2016 and then surged by 69,145,500.00% in 2020.
- Over the past 5 years, Outlook Therapeutics' Shares Issued (Quarterly) stood at $3,013 in 2016, then reached $676,776 in 2017, then reached $11.9 million in 2018, then slumped by 99.51% to $58,278 in 2019, then soared by 69,145,500.00% to $691,456 in 2020.
- Its last three reported values are $691,456 in Q3 2020, $16.0 million for Q2 2020, and $9.4 million during Q1 2020.